Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV⩾100cc

Overview of attention for article published in Radiotherapy & Oncology, December 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 17,404 followers.

RT @DrewMoghanaki: N Korea may be testing nukes, but Japan is testing SBRT doses for NSCLC tumors >100 cc (JCOG 0702). #radonc #lcsm https:…

N Korea may be testing nukes, but Japan is testing SBRT doses for NSCLC tumors >100 cc (JCOG 0702). #radonc #lcsm https://t.co/uYFApg4hWb

R&O: "Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0… https://t.co/PcyHBl70Er

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.